Human immunodeficiency virus reverse transcriptase and protease sequence database

被引:61
|
作者
Shafer, RW [1 ]
Jung, DR
Betts, BJ
Xi, YO
Gonzales, MJ
机构
[1] Stanford Univ, Med Ctr, Div Infect Dis, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Engn, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
关键词
D O I
10.1093/nar/28.1.346
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV RT and Protease Sequence Database is an online relational database that catalogs evolutionary and drug-related human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease sequence variation (http://hivdb.stanford.edu), The database contains a compilation of nearly all published HIV RT and protease sequences including International Collaboration database submissions (e.g., GenBank) and sequences published in journal articles, Sequences are linked to data about the source of the sequence sample and the antiretroviral drug treatment history of the individual from whom the isolate was obtained, The database is curated and sequences are annotated with data from >230 literature references. Users can retrieve additional data and view alignments of sequence sets meeting specific criteria (e.g,, treatment history, subtype, presence of a particular mutation), A gene-specific sequence analysis program, new user-defined queries and nearly 2000 additional sequences were added in 1999.
引用
收藏
页码:346 / 348
页数:3
相关论文
共 50 条
  • [31] HUMAN-IMMUNODEFICIENCY-VIRUS - PLAYING CHESS WITH REVERSE-TRANSCRIPTASE
    RICHMAN, DD
    NATURE, 1993, 361 (6413) : 588 - 589
  • [32] Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery
    Rhee, Soo-Yon
    Margeridon-Thermet, Severine
    Nguyen, Mindie H.
    Liu, Tommy F.
    Kagan, Ron M.
    Beggel, Bastian
    Verheyen, Jens
    Kaiser, Rolf
    Shafer, Robert W.
    ANTIVIRAL RESEARCH, 2010, 88 (03) : 269 - 275
  • [33] Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivity
    de la Carrière, LC
    Paulous, S
    Clavel, F
    Mammano, F
    JOURNAL OF VIROLOGY, 1999, 73 (04) : 3455 - 3459
  • [34] Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent
    Snoeck, J
    Kantor, R
    Shafer, RW
    Van Laethem, K
    Deforche, K
    Carvalho, AP
    Wynhoven, B
    Soares, MA
    Cane, P
    Clarke, J
    Pillay, C
    Sirivichayakul, S
    Ariyoshi, K
    Holguin, A
    Rudich, H
    Rodrigues, R
    Bouzas, MB
    Brun-Vézinet, F
    Reid, C
    Cahn, P
    Brigido, LF
    Grossman, Z
    Soriano, V
    Sugiura, W
    Tanuri, A
    Harrigan, RP
    Camacho, R
    Schapiro, JM
    Katzenstein, D
    Vandamme, AM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 694 - 701
  • [35] ANTI-(HUMAN IMMUNODEFICIENCY VIRUS) ACTIVITY OF POLYOXOTUNGSTATES AND THEIR INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    MOORE, PS
    JONES, CJ
    MAHMOOD, N
    EVANS, IG
    GOFF, M
    COOPER, R
    HAY, AJ
    BIOCHEMICAL JOURNAL, 1995, 307 : 129 - 134
  • [36] Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations
    Monno, L
    Appice, A
    Cavaliere, R
    Scarabaggio, T
    Angarano, G
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 568 - 570
  • [37] Evaluation of adefovir (PMEA) and PMPA in combination with reverse transcriptase and protease inhibitors against human immunodeficiency virus replication in vitro
    Cherrington, JM
    Mulato, AS
    Chen, MS
    AIDS, 1996, 10 : P108 - P108
  • [38] Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer
    Wapling, J
    Moore, KL
    Sonza, S
    Mak, J
    Tachedjian, G
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10247 - 10257
  • [39] ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase
    Naeger, LK
    Margot, NA
    Miller, MD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2179 - 2184
  • [40] DOMAIN-STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    LEDERER, H
    SCHATZ, O
    MAY, R
    CRESPI, H
    DARLIX, JL
    LEGRICE, SFJ
    HEUMANN, H
    EMBO JOURNAL, 1992, 11 (03): : 1131 - 1139